South Korea's Ministry of Food and Drug Safety has fined Novartis $174,937 and temporarily banned sales of some of its drugs for paying kickbacks to doctors.
The ministry placed a fine on 30 drug items and banned sales of 12 variations of 3 drug types including Alzheimer's drug Exelon for three months, reported Reuters. The sales ban will be effective from March 17 through June 16.
Read the Reuters article